These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34040190)

  • 1. Somatic PIK3R1 variation as a cause of vascular malformations and overgrowth.
    Cottrell CE; Bender NR; Zimmermann MT; Heusel JW; Corliss M; Evenson MJ; Magrini V; Corsmeier DJ; Avenarius M; Dudley JN; Johnston JJ; Lindhurst MJ; Vigh-Conrad K; Davies OMT; Coughlin CC; Frieden IJ; Tollefson M; Zaenglein AL; Ciliberto H; Tosi LL; Semple RK; Biesecker LG; Drolet BA
    Genet Med; 2021 Oct; 23(10):1882-1888. PubMed ID: 34040190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic Loss-of-Function PIK3R1 and Activating Non-hotspot PIK3CA Mutations Associated with Capillary Malformation with Dilated Veins (CMDV).
    De Bortoli M; Queisser A; Pham VC; Dompmartin A; Helaers R; Boutry S; Claus C; De Roo AK; Hammer F; Brouillard P; Abdelilah-Seyfried S; Boon LM; Vikkula M
    J Invest Dermatol; 2024 Sep; 144(9):2066-2077.e6. PubMed ID: 38431221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A somatic splice-site variant in PIK3R1 in a patient with vascular overgrowth and low immunoglobulin levels: A case report.
    Wilke MVMB; Schimmenti L; Lopour MQR; Tollefson MM; Klee EW
    Mol Genet Genomic Med; 2023 Dec; 11(12):e2271. PubMed ID: 37641480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
    Akgumus G; Chang F; Li MM
    J Mol Diagn; 2017 Jul; 19(4):487-497. PubMed ID: 28502730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrofacial vascular metameric syndrome is caused by somatic pathogenic variants in
    Sheppard SE; Sanders VR; Srinivasan A; Finn LS; Adams D; Elton A; Amlie-Lefond C; Nelson Z; Dmyterko V; Jensen D; Zenner K; Perkins J; Bennett JT
    Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34887309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis enabling precision medicine treatment in a young boy with PIK3R1-related overgrowth.
    Schönewolf-Greulich B; Karstensen HG; Hjortshøj TD; Jørgensen FS; Harder KM; Frevert S; Hove H; Diness BR
    Eur J Med Genet; 2022 Oct; 65(10):104590. PubMed ID: 35964931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of clinical high-depth next generation sequencing for somatic variant detection in the PIK3CA-related overgrowth spectrum.
    Hucthagowder V; Shenoy A; Corliss M; Vigh-Conrad KA; Storer C; Grange DK; Cottrell CE
    Clin Genet; 2017 Jan; 91(1):79-85. PubMed ID: 27307077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum.
    Keppler-Noreuil KM; Sapp JC; Lindhurst MJ; Parker VE; Blumhorst C; Darling T; Tosi LL; Huson SM; Whitehouse RW; Jakkula E; Grant I; Balasubramanian M; Chandler KE; Fraser JL; Gucev Z; Crow YJ; Brennan LM; Clark R; Sellars EA; Pena LD; Krishnamurty V; Shuen A; Braverman N; Cunningham ML; Sutton VR; Tasic V; Graham JM; Geer J; Henderson A; Semple RK; Biesecker LG
    Am J Med Genet A; 2014 Jul; 164A(7):1713-33. PubMed ID: 24782230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth via Cancer Genomics.
    Siegel DH; Cottrell CE; Streicher JL; Schilter KF; Basel DG; Baselga E; Burrows PE; Ciliberto HM; Vigh-Conrad KA; Eichenfield LF; Holland KE; Hogeling M; Jensen JN; Kelly ME; Kim W; King DM; McCuaig C; Mueller KA; Pope E; Powell J; Price H; Steiner JE; Frieden IJ; Tollefson MM; Drolet BA
    J Invest Dermatol; 2018 Apr; 138(4):957-967. PubMed ID: 29174369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation.
    Keppler-Noreuil KM; Rios JJ; Parker VE; Semple RK; Lindhurst MJ; Sapp JC; Alomari A; Ezaki M; Dobyns W; Biesecker LG
    Am J Med Genet A; 2015 Feb; 167A(2):287-95. PubMed ID: 25557259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors.
    Loconte DC; Grossi V; Bozzao C; Forte G; Bagnulo R; Stella A; Lastella P; Cutrone M; Benedicenti F; Susca FC; Patruno M; Varvara D; Germani A; Chessa L; Laforgia N; Tenconi R; Simone C; Resta N
    PLoS One; 2015; 10(4):e0123092. PubMed ID: 25915946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex vascular anomalies and tissue overgrowth of limbs associated with increased skin temperature and peripheral venous dilatation: parks weber syndrome or PROS?
    Su LX; Sun Y; Wang Z; Wang D; Yang X; Zheng L; Wen M; Fan X; Cai R
    Hereditas; 2022 Jan; 159(1):1. PubMed ID: 34980271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates on Diagnosis and Treatment of PIK3CA-Related Overgrowth Spectrum.
    Chen H; Gao W; Liu H; Sun B; Hua C; Lin X
    Ann Plast Surg; 2023 May; 90(5S Suppl 2):S209-S215. PubMed ID: 36729078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PIK3CA-related overgrowth syndrome (PROS)].
    Venot Q; Canaud G
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S155-S156. PubMed ID: 28577738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.
    Luks VL; Kamitaki N; Vivero MP; Uller W; Rab R; Bovée JV; Rialon KL; Guevara CJ; Alomari AI; Greene AK; Fishman SJ; Kozakewich HP; Maclellan RA; Mulliken JB; Rahbar R; Spencer SA; Trenor CC; Upton J; Zurakowski D; Perkins JA; Kirsh A; Bennett JT; Dobyns WB; Kurek KC; Warman ML; McCarroll SA; Murillo R
    J Pediatr; 2015 Apr; 166(4):1048-54.e1-5. PubMed ID: 25681199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants.
    Goss JA; Konczyk DJ; Smits P; Sudduth CL; Bischoff J; Liang MG; Greene AK
    Clin Genet; 2020 May; 97(5):736-740. PubMed ID: 31909475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical phenotype of the PIK3R1-related vascular overgrowth syndrome.
    Kuentz P; Engel C; Laeng M; Chevarin M; Duffourd Y; Martel J; Piard J; Morice-Picard F; Aubert H; Bessis D; Guerrot AM; Maruani A; Boccara O; Mazereeuw-Hautier J; Ott H; Phan A; Puzenat E; Quelin C; Thauvin-Robinet C; Faivre L; Vabres P
    Br J Dermatol; 2024 Jul; 191(2):303-305. PubMed ID: 38623710
    [No Abstract]   [Full Text] [Related]  

  • 18. CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS).
    Martinez-Lopez A; Blasco-Morente G; Perez-Lopez I; Herrera-Garcia JD; Luque-Valenzuela M; Sanchez-Cano D; Lopez-Gutierrez JC; Ruiz-Villaverde R; Tercedor-Sanchez J
    Clin Genet; 2017 Jan; 91(1):14-21. PubMed ID: 27426476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA mutation in cultured amniocytes.
    Emrick LT; Murphy L; Shamshirsaz AA; Ruano R; Cassady CI; Liu L; Chang F; Sutton VR; Li M; Van den Veyver IB
    Am J Med Genet A; 2014 Oct; 164A(10):2633-7. PubMed ID: 25044986
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.